Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
BMJ Open|December 9, 2016
Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal studyDan-Qin Sun, Sheng-Jie Wu, Wen-Yue Liu, et al.
European Journal of Gastroenterology & Hepatology|July 27, 2017
Development of a prognostic nomogram for cirrhotic patients with upper gastrointestinal bleedingYu-Jie Zhou, Ji-Na Zheng, Yi-Fan Zhou, et al.
Medicine|May 19, 2015
Increased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver diseaseSheng-Jie Wu, Hai Zou, Gui-Qi Zhu, et al.
Medicine|February 6, 2015
Nonalcoholic fatty liver disease: a negative risk factor for colorectal cancer prognosisJie You, Sha Huang, Gui-Qian Huang, et al.
Expert Opinion on Therapeutic Targets|December 31, 2014
Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic targetWen-Yue Liu, Dong-Mei Xie, Gui-Qi Zhu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 19, 2018
Translational Biomarkers and Ex Vivo Models of Joint Tissues as a Tool for Drug Development in Rheumatoid ArthritisCecilie F Kjelgaard-Petersen, Adam Platt, Martin Braddock, et al.
Medicine|May 2, 2015
Association between sex-specific serum uric acid and non-alcoholic fatty liver disease in Chinese adults: a large population-based studySheng-Jie Wu, Gui-Qi Zhu, Bo-Zhi Ye, et al.
Oncotarget|June 26, 2015
Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysisGui-Qi Zhu, Sha Huang, Gui-Qian Huang, et al.
Plos One|June 10, 2015
Establishment and Validation of SSCLIP Scoring System to Estimate Survival in Hepatocellular Carcinoma Patients Who Received Curative Liver ResectionSha Huang, Gui-Qian Huang, Gui-Qi Zhu, et al.
The Lancet. Respiratory Medicine|May 26, 2018
Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trialRichard J Russell, Latifa Chachi, J Mark FitzGerald, et al.
Pageof 8